139 related articles for article (PubMed ID: 7577347)
1. Cytomegalovirus infection in marrow transplantation.
Boeckh M; Bowden R
Cancer Treat Res; 1995; 76():97-136. PubMed ID: 7577347
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
[No Abstract] [Full Text] [Related]
3. Diagnosis and treatment of cytomegalovirus infection after renal transplantation.
Guandelin M; Xiuwu H; Juzhong G; Juanjun X; Zhiyou H
Transplant Proc; 2000 Nov; 32(7):1930-1. PubMed ID: 11120006
[No Abstract] [Full Text] [Related]
4. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
5. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
[TBL] [Abstract][Full Text] [Related]
6. Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
Hebart H; Brugger W; Grigoleit U; Gscheidle B; Loeffler J; Schäfer H; Kanz L; Einsele H; Sinzger C
Blood; 2001 Apr; 97(7):2183-5. PubMed ID: 11286223
[No Abstract] [Full Text] [Related]
7. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
9. Effective strategies to prevent cytomegalovirus disease after renal transplantation.
Chapman JR
Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809
[No Abstract] [Full Text] [Related]
10. Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation.
Waid TH; McKeown JW
Transplant Proc; 1995 Oct; 27(5 Suppl 1):46. PubMed ID: 7482820
[No Abstract] [Full Text] [Related]
11. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus disease with Guillain-Barré syndrome in a cadaver renal allograft recipient: cause or coincidence.
Keithi-Reddy SR; Chakravarthi RM; Hussaini SM; Venkatapuram RR; Murthy JM
Int Urol Nephrol; 2007; 39(3):967-70. PubMed ID: 17450421
[TBL] [Abstract][Full Text] [Related]
13. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
[No Abstract] [Full Text] [Related]
14. [Infections in bone marrow transplantation].
Villasís-Keever A; Mosqueda JL
Rev Invest Clin; 2005; 57(2):381-6. PubMed ID: 16524081
[No Abstract] [Full Text] [Related]
15. Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins.
Séchet A; Bridoux F; Bauwens M; Ayache RA; Belmouaz S; Touchard G
Transplant Proc; 2002 May; 34(3):812-3. PubMed ID: 12034192
[No Abstract] [Full Text] [Related]
16. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
17. Cytomegalovirus prophylaxis and treatment following bone marrow transplantation.
Tsinontides AC; Bechtel TP
Ann Pharmacother; 1996 Nov; 30(11):1277-90. PubMed ID: 8913411
[TBL] [Abstract][Full Text] [Related]
18. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients.
Roberts TC; Brennan DC; Buller RS; Gaudreault-Keener M; Schnitzler MA; Sternhell KE; Garlock KA; Singer GG; Storch GA
J Infect Dis; 1998 Sep; 178(3):626-35. PubMed ID: 9728529
[TBL] [Abstract][Full Text] [Related]
19. Pancytopenia in allogeneic marrow transplant recipients: role of cytomegalovirus.
Bilgrami S; Almeida GD; Quinn JJ; Tuck D; Bergstrom S; Dainiak N; Poliquin C; Ascensao JL
Br J Haematol; 1994 Jun; 87(2):357-62. PubMed ID: 7947279
[TBL] [Abstract][Full Text] [Related]
20. Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
Jung C; Engelmann E; Borner K; Offermann G
Transplant Proc; 2001; 33(7-8):3621-3. PubMed ID: 11750538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
